- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x UTD: 4-(4-cyclohexyl-3,4-dihydro-2~{H}-pyridin-1-yl)-1-(4-$l^{2}-fluoranylcyclohexa-1,3,5-trien-1-yl)butan-1-one(Non-covalent)
UTD.1: 13 residues within 4Å:- Chain A: W.33, D.46, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422
- Ligands: GOL.10
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:A.53, A:W.56, A:W.56, A:L.83, A:F.104
- Salt bridges: A:E.421
UTD.13: 13 residues within 4Å:- Chain B: W.33, D.46, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422
- Ligands: GOL.22
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:A.53, B:W.56, B:W.56, B:L.83, B:F.104
- Salt bridges: B:E.421
UTD.25: 13 residues within 4Å:- Chain C: W.33, D.46, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422
- Ligands: GOL.34
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:A.53, C:W.56, C:W.56, C:L.83, C:F.104
- Salt bridges: C:E.421
UTD.37: 13 residues within 4Å:- Chain D: W.33, D.46, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422
- Ligands: GOL.46
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:A.53, D:W.56, D:W.56, D:L.83, D:F.104
- Salt bridges: D:E.421
UTD.49: 13 residues within 4Å:- Chain E: W.33, D.46, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422
- Ligands: GOL.58
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:A.53, E:W.56, E:W.56, E:L.83, E:F.104
- Salt bridges: E:E.421
UTD.61: 13 residues within 4Å:- Chain F: W.33, D.46, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422
- Ligands: GOL.70
6 PLIP interactions:6 interactions with chain F- Hydrophobic interactions: F:A.53, F:W.56, F:W.56, F:L.83, F:F.104
- Salt bridges: F:E.421
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.2: 9 residues within 4Å:- Chain A: L.261, H.269, I.287, I.288, T.289, H.290, D.293, P.294, Q.417
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:I.288, A:T.289
- Water bridges: A:L.261, A:R.262
PEG.14: 9 residues within 4Å:- Chain B: L.261, H.269, I.287, I.288, T.289, H.290, D.293, P.294, Q.417
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:I.288, B:T.289
- Water bridges: B:L.261, B:R.262
PEG.26: 9 residues within 4Å:- Chain C: L.261, H.269, I.287, I.288, T.289, H.290, D.293, P.294, Q.417
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:I.288, C:T.289
- Water bridges: C:L.261, C:R.262
PEG.38: 9 residues within 4Å:- Chain D: L.261, H.269, I.287, I.288, T.289, H.290, D.293, P.294, Q.417
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:I.288
- Water bridges: D:L.261, D:R.262
PEG.50: 9 residues within 4Å:- Chain E: L.261, H.269, I.287, I.288, T.289, H.290, D.293, P.294, Q.417
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:I.288
- Water bridges: E:L.261, E:R.262
PEG.62: 9 residues within 4Å:- Chain F: L.261, H.269, I.287, I.288, T.289, H.290, D.293, P.294, Q.417
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:I.288
- Water bridges: F:L.261, F:R.262
- 42 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 6 residues within 4Å:- Chain A: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.6: 4 residues within 4Å:- Chain A: A.171, D.172
- Chain E: N.393, R.396
Ligand excluded by PLIPGOL.7: 4 residues within 4Å:- Chain A: I.288, T.418, A.419, E.421
Ligand excluded by PLIPGOL.8: 6 residues within 4Å:- Chain A: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.9: 10 residues within 4Å:- Chain A: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: GOL.10
Ligand excluded by PLIPGOL.10: 7 residues within 4Å:- Chain A: F.44, D.46, S.103, F.104, F.422
- Ligands: UTD.1, GOL.9
Ligand excluded by PLIPGOL.11: 9 residues within 4Å:- Chain A: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPGOL.15: 6 residues within 4Å:- Chain B: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.18: 4 residues within 4Å:- Chain B: A.171, D.172
- Chain D: N.393, R.396
Ligand excluded by PLIPGOL.19: 4 residues within 4Å:- Chain B: I.288, T.418, A.419, E.421
Ligand excluded by PLIPGOL.20: 6 residues within 4Å:- Chain B: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.21: 10 residues within 4Å:- Chain B: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: GOL.22
Ligand excluded by PLIPGOL.22: 7 residues within 4Å:- Chain B: F.44, D.46, S.103, F.104, F.422
- Ligands: UTD.13, GOL.21
Ligand excluded by PLIPGOL.23: 9 residues within 4Å:- Chain B: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPGOL.27: 6 residues within 4Å:- Chain C: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.30: 4 residues within 4Å:- Chain C: A.171, D.172
- Chain F: N.393, R.396
Ligand excluded by PLIPGOL.31: 4 residues within 4Å:- Chain C: I.288, T.418, A.419, E.421
Ligand excluded by PLIPGOL.32: 6 residues within 4Å:- Chain C: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.33: 10 residues within 4Å:- Chain C: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: GOL.34
Ligand excluded by PLIPGOL.34: 7 residues within 4Å:- Chain C: F.44, D.46, S.103, F.104, F.422
- Ligands: UTD.25, GOL.33
Ligand excluded by PLIPGOL.35: 9 residues within 4Å:- Chain C: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPGOL.39: 6 residues within 4Å:- Chain D: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.42: 4 residues within 4Å:- Chain B: N.393, R.396
- Chain D: A.171, D.172
Ligand excluded by PLIPGOL.43: 4 residues within 4Å:- Chain D: I.288, T.418, A.419, E.421
Ligand excluded by PLIPGOL.44: 6 residues within 4Å:- Chain D: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.45: 10 residues within 4Å:- Chain D: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: GOL.46
Ligand excluded by PLIPGOL.46: 7 residues within 4Å:- Chain D: F.44, D.46, S.103, F.104, F.422
- Ligands: UTD.37, GOL.45
Ligand excluded by PLIPGOL.47: 9 residues within 4Å:- Chain D: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPGOL.51: 6 residues within 4Å:- Chain E: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.54: 4 residues within 4Å:- Chain A: N.393, R.396
- Chain E: A.171, D.172
Ligand excluded by PLIPGOL.55: 4 residues within 4Å:- Chain E: I.288, T.418, A.419, E.421
Ligand excluded by PLIPGOL.56: 6 residues within 4Å:- Chain E: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.57: 10 residues within 4Å:- Chain E: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: GOL.58
Ligand excluded by PLIPGOL.58: 7 residues within 4Å:- Chain E: F.44, D.46, S.103, F.104, F.422
- Ligands: UTD.49, GOL.57
Ligand excluded by PLIPGOL.59: 9 residues within 4Å:- Chain E: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPGOL.63: 6 residues within 4Å:- Chain F: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.66: 4 residues within 4Å:- Chain C: N.393, R.396
- Chain F: A.171, D.172
Ligand excluded by PLIPGOL.67: 4 residues within 4Å:- Chain F: I.288, T.418, A.419, E.421
Ligand excluded by PLIPGOL.68: 6 residues within 4Å:- Chain F: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.69: 10 residues within 4Å:- Chain F: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: GOL.70
Ligand excluded by PLIPGOL.70: 7 residues within 4Å:- Chain F: F.44, D.46, S.103, F.104, F.422
- Ligands: UTD.61, GOL.69
Ligand excluded by PLIPGOL.71: 9 residues within 4Å:- Chain F: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIP- 12 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.4: 2 residues within 4Å:- Chain A: E.159, W.309
3 PLIP interactions:3 interactions with chain A- Salt bridges: A:E.159
- pi-Cation interactions: A:W.309, A:W.309
DMS.5: 7 residues within 4Å:- Chain A: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.370
- Salt bridges: A:E.370
DMS.16: 2 residues within 4Å:- Chain B: E.159, W.309
3 PLIP interactions:3 interactions with chain B- Salt bridges: B:E.159
- pi-Cation interactions: B:W.309, B:W.309
DMS.17: 7 residues within 4Å:- Chain B: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.370
- Salt bridges: B:E.370
DMS.28: 2 residues within 4Å:- Chain C: E.159, W.309
3 PLIP interactions:3 interactions with chain C- Salt bridges: C:E.159
- pi-Cation interactions: C:W.309, C:W.309
DMS.29: 7 residues within 4Å:- Chain C: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:E.370
- Salt bridges: C:E.370
DMS.40: 2 residues within 4Å:- Chain D: E.159, W.309
3 PLIP interactions:3 interactions with chain D- Salt bridges: D:E.159
- pi-Cation interactions: D:W.309, D:W.309
DMS.41: 7 residues within 4Å:- Chain D: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:E.370
- Salt bridges: D:E.370
DMS.52: 2 residues within 4Å:- Chain E: E.159, W.309
3 PLIP interactions:3 interactions with chain E- Salt bridges: E:E.159
- pi-Cation interactions: E:W.309, E:W.309
DMS.53: 7 residues within 4Å:- Chain E: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:E.370
- Salt bridges: E:E.370
DMS.64: 2 residues within 4Å:- Chain F: E.159, W.309
3 PLIP interactions:3 interactions with chain F- Salt bridges: F:E.159
- pi-Cation interactions: F:W.309, F:W.309
DMS.65: 7 residues within 4Å:- Chain F: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:E.370
- Salt bridges: F:E.370
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.12: 4 residues within 4Å:- Chain A: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.24: 4 residues within 4Å:- Chain B: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.36: 4 residues within 4Å:- Chain C: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.48: 4 residues within 4Å:- Chain D: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.60: 4 residues within 4Å:- Chain E: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.72: 4 residues within 4Å:- Chain F: T.289, H.290, Q.417, T.418
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Punetha, A. et al., Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance. Rsc Med Chem (2021)
- Release Date
- 2021-06-02
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
AAAC
AAAD
AAAE
AAAF
AAA
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x UTD: 4-(4-cyclohexyl-3,4-dihydro-2~{H}-pyridin-1-yl)-1-(4-$l^{2}-fluoranylcyclohexa-1,3,5-trien-1-yl)butan-1-one(Non-covalent)
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 42 x GOL: GLYCEROL(Non-functional Binders)
- 12 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Punetha, A. et al., Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance. Rsc Med Chem (2021)
- Release Date
- 2021-06-02
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
AAAC
AAAD
AAAE
AAAF
AAA